UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: C | D | F | G | L | M | O | P | S
Number of items: 19.

C

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Selden, C; Sim, R; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. JOURNAL OF HEPATOLOGY , 38 38 - 38.

D

Davies, JK; Joh, MB; Prentice, HG; Lowdell, MW; (2003) Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3. In: Biology of Blood and Marrow Transplantation.

Davies, JK; Koh, MB; Verfuerth, S; Mackinnon, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells within the donor cell pool. In: BLOOD. (pp. 965A - 965A). AMER SOC HEMATOLOGY

Davies, JK; Koh, MBC; Verfeurth, S; MACKINNON, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells. In: (pp. 965 - ?).

Davies, JK; Lowdell, MW; (2003) New advances in acute graft-versus-host disease prophylaxis. TRANSFUSION MED , 13 (6) 387 - 397.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD , 102 (11) 3542 - ?.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. In: BLOOD. (pp. 951A - 951A). AMER SOC HEMATOLOGY

Davies, JK; Marden, CM; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach. In: (pp. 951 - ?).

F

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; ... Ganeshaguru, K; + view all (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY

G

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; ... Wickremasinghe, RG; + view all (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY

L

Lowdell, MW; (2003) "Out damned spot": ex vivo purging revisited. BLOOD , 102 (12) 3860 - 3861.

Lowdell, MW; (2003) Natural killer cells in haematopoietic stem cell transplantation. TRANSFUSION MED , 13 (6) 399 - 404.

M

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: (pp. 964 - ?).

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD , 102 (11) 3591 - ?.

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: BLOOD. (pp. 964A - 964A). AMER SOC HEMATOLOGY

O

Orleans-Lindsay, JK; Deru, A; Craig, JIO; Prentice, HG; Lowdell, MW; (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475.

P

Pamphilon, DH; Lowdell, MW; (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324.

S

Smith, L; Lowdell, MW; (2003) Quality issues in stem cell and immunotherapy laboratories. TRANSFUSION MED , 13 (6) 417 - 423.

This list was generated on Sun Jul 27 15:42:04 2014 BST.